AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Carasent

AGM Information Mar 26, 2024

3568_rns_2024-03-26_4ec2bba4-7eba-485a-9495-aea7d2edde0b.pdf

AGM Information

Open in Viewer

Opens in native device viewer

The nomination committee's proposal and motivated statement for the annual general meeting of Carasent ASA on April 17, 2024

For the annual general meeting 2024, the nomination committee consists of Niclas Hugosson and Niclas Lindlöf. Niclas Hugosson is the chairman of the nomination committee, and the committee has submitted the following proposals for resolution.

1. Determination of the number of board members

The board currently consists of four (4) board members, including the chairman of the board. The nomination committee proposes that the board of directors shall consist of five (5) board members, including the chairman of the board.

2. Election of board members

The nomination committee proposes that the annual general meeting shall re-elect the board members Petri Niemi, Ulrika Cederskog Sundling and Camilla Skoog for a 2-year term. To further strengthen the board with relevant experience from the healthcare software sector, the nomination committee proposes that Henric Carlsson is elected as new board member for a 2-year term.

Short presentation of Henric Carlsson:

Henric Carlsson, born in 1970 and a Swedish citizen, started his career in the pharmaceutical industry, advancing through various sales and marketing roles within global pharmaceutical companies, such as Roche. Henric subsequently co-founded Omilon, a healthcare software company utilising AI to improve efficiency across Nordic healthcare. Henric brings over 18 years of experience in healthcare software and the intersection between AI and electronic medical records, including the application of speech recognition to improve the efficiency of care.

Name Position st Elected
1
Current election term Proposal
Petri Niemi Chairman 2022 October 19, 2022 for 2 years Re-elected
Ulrika Cederskog Member 2022 April 28, 2022 for 2 years Re-elected
Sundling
Camilla Skoog Member 2022 April 28, 2022 for 2 years Re-elected
Tomas Meerits Member 2021 May 3, 2023 for 2 years Continue
Henric Carlsson Member 2024 April 17, 2024 for 2 years Elected

If the nomination committee's proposals are resolved, the board's composition will be:

Board shareholdings and independence:

Name Position Shareholding Independence
Petri Niemi Chairman 12,264 Independent
Ulrika Cederskog Member 20,000 Independent
Sundling
Camilla Skoog Member 9,345 Independent
Tomas Meerits Member - Vitruvian Partners
Henric Carlsson Member - Independent

Based on the proposed composition of the board, all directors will be independent in relation to the Company and its management. The majority of directors will be independent in relation to major shareholders.

3. Proposal for remuneration to the board of directors and the audit committee

The nomination committee has reviewed board fees considering responsibilities, expected workload and market conditions and proposes that the remuneration to the board of directors shall remain unchanged and be NOK 1,500,000, distributed as follows: NOK 250,000 to each board member, and NOK 500,000 to the chairman of the board.

Remuneration for work in the audit committee is proposed to be NOK 10,000 per meeting for its chairman, and NOK 5,000 per meeting for other audit committee members, which the committee considers reflect work load and marked conditions.

4. Proposal for new members of the Nomination Committee

The nomination committee has consulted the major shareholders of Carasent ASA and propose the election of the following members to the committee for a 2-year term:

Name Position st Elected
1
Current election term Proposal
Niclas Lindlöf Chairman 2022 April 28, 2022 Re-elected
Jesper Jannerberg Member New April 28, 2022 for 2 years Elected
Peder Strand Member New April 28, 2022 for 2 years Elected

Short presentation of the two new candidates:

Jesper Jannerberg was born in 1969 and is a Swedish citizen. Jesper possesses over 25 years of extensive experience in the Swedish IT and software sector. With a background in establishing and leading companies, he has notably contributed to the evolution of several enterprises. His proficiency extends to IT solutions in the Swedish healthcare domain. Presently, Jesper operates his own consulting and investment business. Previously, Jesper held the position of CEO at Carasent and was a key founding figure of the entity as it stands today. Jesper controls today 3,11% of the shares in Carasent.

Peder Strand was born 1980 and is a Norwegian citizen. Previously a partner in Arctic Securities AS, where he was responsible for the seafood, IT and healthcare sectors. Strand has previously worked in equity research for SEB Enskilda, among other things as the responsible analyst for seafood. Currently Investment director at Seatankers Management Company Limited

Motivated statement

The fiduciary responsibility of the nomination committee is to act in the interest of all shareholders of the Company, with the aim of finding an optimal board which balances current and future needs.

The nomination committee concludes that it is important that the proposed board can continue to support Carasent's current strategy and is confident that, with the addition of one highly qualified board member, Carasent's further growth is well supported.

Continued attention has been paid to securing that the board has a composition which is characterised by a breadth of qualifications and experiences as well as a fair gender balance. The proposed board consists of three men (60%) and two women (40%). The nomination committee is committed to continue its efforts to further improve the gender balance of the board.

Stockholm, March 2024

THE NOMINATION COMMITTEE OF Carasent Asa

Talk to a Data Expert

Have a question? We'll get back to you promptly.